← Back to Patent Explorer
US4600689A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel bilirubin oxidase, its production and use

Assignee: Takara Shuzo Co Ltd
•
Filing: 1984-09-10
•
Granted: 1986-07-15
•
Expires: 2004-09-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to a novel bilirubin oxidase produced by a strain belonging to the genus Trachyderma of the class Basidiomycetes and its production, a reagent composition for bilirubin containing said novel bilirubin oxidase, a method for the quantitative determination of bilirubin in test solutions such as biological fluids with said reagent composition, and a method for applying said reagent composition to analytical methods in which the interfering effect of bilirubin needs to be eliminated.

Inventors

  • 👤 Susumu Matsui
  • 👤 Yoshio Yoshihama
  • 👤 Tsutomu Taniguchi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 10:57
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/72; C; C12; C12Q; C12Q1/00; C12Q1/26; C12N; C12N9/00; C12N9/0004; C12N9/001; C12Y; C12Y103/00; C12Y103/03; C12Y103/03005; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/911

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 180 words
A bilirubin oxidase M-1 having the following physicochemical properties: (1) Action: Has an action to oxidize bilirubin in the presence of oxygen far into an almost colorless substance through biliverdin and then a pale violet substance, but forms no hydrogen peroxide; (2) Substrate specificity: Acts on bilirubin and to some degree on biliverdin as well as on phenol, catechol and hydroquinone; (3) Optimum pH and pH stability: Has an optimum pH in the vicinity of 5.5, and is stable between pH 5 and pH 9 for 60 minutes treatment at 37° C. (4) Optimum temperature and thermal stability: Has an optimum temperature in the vicinity of 50° C. and is stable up 55° C. for 10 minutes treatment at a pH of 7.0; (5) Molecular weight: About 83,000 (gel filtration method); (6) Isoelectric point: 3.92±0.05; (7) Interfering agent: Inhibited by sodium azide, L-ascorbic acid, dithiothreitol and potassium cyanide; (8) Visible absorption spectrum: Has an absorption maximum in the vicinity of 610 nm; (9) Sugar content: Contains about 4.5% of sugar; (10) Copper content: Contains 4 moles of copper per mole.
Claim 2
Dependent Claim 180 words
A bilirubin oxidase M-1 having the following physicochemical properties: (1) Action: Has an action to oxidize bilirubin in the presence of oxygen far into an almost colorless substance through biliverdin and then a pale violet substance, but forms no hydrogen peroxide; (2) Substrate specificity: Acts on bilirubin and to some degree on biliverdin as well as on phenol, catechol and hydroquinone; (3) Optimum pH and pH stability: Has an optimum pH in the vicinity of 5.5, and is stable between pH 5 and pH 9 for 60 minutes treatment at 37° C. (4) Optimum temperature and thermal stability: Has an optimum temperature in the vicinity of 50° C. and is stable up 55° C. for 10 minutes treatment at a pH of 7.0; (5) Molecular weight: About 83,000 (gel filtration method); (6) Isoelectric point: 3.92±0.05; (7) Interfering agent: Inhibited by sodium azide, L-ascorbic acid, dithiothreitol and potassium cyanide; (8) Visible absorption spectrum: Has an absorption maximum in the vicinity of 610 nm; (9) Sugar content: Contains about 4.5% of sugar; (10) Copper content: Contains 4 moles of copper per mole.
Claim 3
Dependent Claim 18 words
The reagent composition for bilirubin characterized in that said composition contains the bilirubin oxidase M-1 of claim 1.
Claim 4
Dependent Claim 16 words
The reagent composition for bilirubin as described in claim 2 containing the salt of deoxycholic acid.
Claim 5
Dependent Claim 41 words
A method for the quantitative determination of bilirubin wherein a reagent composition for bilirubin containing the bilirubin oxidase M-1 of claim 1 is caused to act on a bilirubin-containing test solution and a change in bilirubin caused thereby is measured colorimetrically.
Claim 6
Dependent Claim 16 words
The method as described in claim 4, wherein said composition contains the salt of deoxycholic acid.
Claim 7
Dependent Claim 52 words
The method for the quantitative determination of bilirubin wherein 3-methyl-2-benzothiazolinone-hydrazone and a reagent composition for bilirubin containing the bilirubin oxidase M-1 of claim 1 are added to a bilirubin-containing test solution, the mixed solution is brought into reaction, and after acidifying the reaction solution, bilirubin is quantitatively determined by the colorimetric method.
Claim 8
Dependent Claim 87 words
In a method for analyzing components other than bilirubin in a bilirubin-containing test solution by utilizing reaction with oxidase, peroxidase and a hydrogen-donative chromogen in which method bilirubin acts as an interfering agent, the improvement wherein said method includes (A) a step of causing a reagent composition for bilirubin containing the bilirubin oxidase M-1 of claim 1 to act on the test solution to eliminate the interfering effect of the coexisting bilirubin and (b) a step of analyzing the desired component present in the remaining test solution.
Claim 9
Dependent Claim 34 words
The analytical method as described in claim 7, wherein an interfering substance for the bilirubin oxidase M-1 is added after the step (a) has been completed, and then the step (b) is carried out.
Claim 10
Dependent Claim 17 words
The analytical method as described in claim 7, wherein said composition contains the salt of deoxycholic acid.
Claim 11
Dependent Claim 44 words
A method for producing the bilirubin oxidase M-1 of claim 1 which comprises cultivating the bilirubin oxidase M-1 producing strain Trachyderma tsunodae K-2593 (FERM BP-387) to produce a culture broth containing bilirubin oxidase M-1 and recovering said bilirubin oxidase M-1 from said culture broth.
Claim 12
Dependent Claim 17 words
An analytical method as described in claim 8 wherein said composition contains the salt of deoxycholic acid.

References Cited (Backward Citations)

US4221844A Cited
JPS57159487A Cited
US4554249A Cited
EP0114381A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-07-14 1990-01-13 1990-07-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-07-14 1994-01-13 1994-07-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-07-14 1998-01-13 1998-07-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag